Industry trends

Purchasing information

Home page

News

The 17th World Pharmaceutical Raw Materials China Exhibition

The 17th World Pharmaceutical Raw Materials China Exhibition

2017-07-21

Fosun Pharmaceuticals acquired 74% equity of Gland74 to build an international platform for preparations

Today, the company announced that it signed the Third Amendment with the existing shareholders and related parties of India Gland, adjusting the transaction to: the company invested no more than US $1091.3 million to acquire about 74% of Gland's equity, including the contingent consideration paid for the listing and sale of Gland Enoxaparin in the United States, which did not exceed US $25 million. The termination date of this transaction is extended to October 3, 2017.

2017-09-20

< 1...4 5 6...12 >

Unlocking the Power of Heparin Sodium: A Game-Changer in Healthcare

2025-11-29

Understanding Heparin Sodium: The Unsung Hero of Anticoagulation

2025-11-26

Unlocking the Secrets of Aprotinin: A Game-Changer in Medicine

2025-11-23

Unlocking the Mysteries of Aprotinin: A Guide to Its Role and Impact

2025-11-20

Congratulations on the establishment of our website

2017-07-18

Panoramic Analysis of China's Foreign Trade in Medical Devices in 2015

2017-07-18

图片名称

©2022 Jiangxi Runquankang Biotechnology Co., Ltd. All rights reserved

| SEO |

图片名称

图片名称

Address: Guantian Industrial Park, Chongyi , Ganzhou, Jiangxi

图片名称

Tel：0791-88610177

图片名称

Phone：15170676666

图片名称

Mail：info@rqkpharm.com

图片名称

图片名称

Scan code to view